🇺🇸 FDA

Company profile · Sponsor

Xiangya

Xiangya Hospital of Central South University

C2159AA · NMPA pharma CN
Pipeline
1
Drugs
0
Patents
0

Quick answer

Xiangya (C2159AA) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 1 pipeline program, 0 drugs, and 0 patents to this profile..

Company facts

Ticker C2159AA
Exchange NMPA
Company type pharma
Headquarters CN

Pipeline (1)

Search pipeline →

  1. Neoadjuvant Chemotherapy

    Xiangya

    High-Grade Upper Tract Urothelial Carcinoma

    phase 2 small molecule completed

    1 trial

Frequently asked questions

What is Xiangya?

Xiangya (C2159AA) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 1 pipeline program, 0 drugs, and 0 patents to this profile..

What pipeline programs does Xiangya sponsor?

We track 1 ClinicalTrials.gov-linked program for Xiangya, including Neoadjuvant Chemotherapy. Open each program for phase, modality, NCT IDs, and indication details.

Where does Xiangya company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.